Form D · Pharmaceuticals
ELLA LEROY Corp
Honolulu, HI · CIK 0002149028
Offering snapshot reported Aug 11, 2026 · SEC filing
- Reported sold
- $50K Offering amount: $75K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 11, 2026 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593821
Source: Form D, filed Aug 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aaric Queen | Executive |
| Sadiqa Queen | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1650 Ala Moana Blvd Apt 4105
Honolulu, HI, 96815-1472
Honolulu, HI, 96815-1472